BibTex RIS Cite

Magnetic resonance cholangio-pancreatography

Year 2012, , 213 - 215, 01.12.2012
https://doi.org/10.5505/sakaryamj.2012.65487

Abstract

Magnetic resonance cholangiopancreatography (MRCP) is a noninvasive technique for evaluating the intrahepatic and extrahepatic bile ducts and the pancreatic duct. In the diagnosis pancreatic and bile ducts disorders, MRCP is a much less invasive investigation and does not require contrast material to be administered into the ductal system when compared to endoscopic retrograde cholangiopancreatography (ERCP).

References

  • Wallner BK, Schumacher KA, Weidenmeier W, Friedrich JM. Dilated biliary tract: evaluation with MR cholangiography with a T2-weighted contrastenhanced fast sequence. Radiology 1991; 181: 805-808.
  • Coakley FV, Qayyum A. Magnetic resonance cholangiopancrea- tography. Gastrointest Endosc 2002;55:S2–12.
  • Sahai AV, Devonshire D, Yeoh KG. The decisionmaking value of magnetic resonance cholangiopancreatography in patients seen in a referral center with suspected biliary and pancreatic disease. Am J Gastroenterol 2001; 96:207–80.
  • Bowes MT, Martin DF, Melling A, Roberts D, Laasch HU, Suku- mar S, Morris J. Single dose oral ranitidine improves MRCP im- age quality: a double-blind study. Clin Radiol 2007; 62:53.
  • Dalal PU, Howlett DC, Sallomi DF, Marchbank ND, Watson GM, Marr A, Dunk AA, Smith AD. Does intravenous glucagon improve common bile duct visualisation during magnetic resonance chol- angiopancreatography? Results in 42 patients. Eur J Radiol 2004; 49:258.
  • Maccioni F, Martinelli M, Al Ansari N, Kagarmanova A, De Marco V, Zippi M, Marini M. Magnetic resonance cholangiography: past, present and future: a review.. Eur Rev Med Pharmacol Sci. 2010 Aug;14(8):721-5
  • Hochwald SN, Rofsky NM, Dobryanski M, Shamamian P, Marcus SG. MR imaging with MR cholangiopancreatography accurately predicts resectability of pancreatic carcinoma.J Gastrointest Surg1999; 3:506-511
  • Bret PM, Reinhold C. Magnetic resonance cholangiopancreatog- raphy. Endoscopy 1997; 29:472.
  • Reinhold C, Bret PM. Current status of MR cholangiopancreatog- raphy. AJR Am J Roentgenol 1996; 166:1285. Gündüz ve Ark.
  • Magnetic Resonance Cholangiopancreatography
  • Sakaryamj 2012;2(4):213-215
  • Farrell RJ, Noonan N, Mahmud N, Morrin MM, Kelleher D, Keel- ing PW. Potential impact of magnetic resonance cholangiopan- creatography on endoscopic retrograde cholangiopancreatogra- phy workload and complication rate in patients referred because
  • of abdominal pain. Endoscopy 2001;33:668–75.
  • Lomas DJ, Gimson A. Magnetic resonance cholangiopancreatog- raphy [review]. Hosp Med 2000;61:395–9.

Magnetic resonance cholangio-pancreatography

Year 2012, , 213 - 215, 01.12.2012
https://doi.org/10.5505/sakaryamj.2012.65487

Abstract

Magnetic resonance cholangiopancreatography (MRCP) is a noninvasive technique for evaluating the intrahepatic and extrahepatic bile ducts and the pancreatic duct. In the diagnosis pancreatic and bile ducts disorders, MRCP is a much less invasive investigation and does not require contrast material to be administered into the ductal system when compared to endoscopic retrograde cholangiopancreatography (ERCP).

References

  • Wallner BK, Schumacher KA, Weidenmeier W, Friedrich JM. Dilated biliary tract: evaluation with MR cholangiography with a T2-weighted contrastenhanced fast sequence. Radiology 1991; 181: 805-808.
  • Coakley FV, Qayyum A. Magnetic resonance cholangiopancrea- tography. Gastrointest Endosc 2002;55:S2–12.
  • Sahai AV, Devonshire D, Yeoh KG. The decisionmaking value of magnetic resonance cholangiopancreatography in patients seen in a referral center with suspected biliary and pancreatic disease. Am J Gastroenterol 2001; 96:207–80.
  • Bowes MT, Martin DF, Melling A, Roberts D, Laasch HU, Suku- mar S, Morris J. Single dose oral ranitidine improves MRCP im- age quality: a double-blind study. Clin Radiol 2007; 62:53.
  • Dalal PU, Howlett DC, Sallomi DF, Marchbank ND, Watson GM, Marr A, Dunk AA, Smith AD. Does intravenous glucagon improve common bile duct visualisation during magnetic resonance chol- angiopancreatography? Results in 42 patients. Eur J Radiol 2004; 49:258.
  • Maccioni F, Martinelli M, Al Ansari N, Kagarmanova A, De Marco V, Zippi M, Marini M. Magnetic resonance cholangiography: past, present and future: a review.. Eur Rev Med Pharmacol Sci. 2010 Aug;14(8):721-5
  • Hochwald SN, Rofsky NM, Dobryanski M, Shamamian P, Marcus SG. MR imaging with MR cholangiopancreatography accurately predicts resectability of pancreatic carcinoma.J Gastrointest Surg1999; 3:506-511
  • Bret PM, Reinhold C. Magnetic resonance cholangiopancreatog- raphy. Endoscopy 1997; 29:472.
  • Reinhold C, Bret PM. Current status of MR cholangiopancreatog- raphy. AJR Am J Roentgenol 1996; 166:1285. Gündüz ve Ark.
  • Magnetic Resonance Cholangiopancreatography
  • Sakaryamj 2012;2(4):213-215
  • Farrell RJ, Noonan N, Mahmud N, Morrin MM, Kelleher D, Keel- ing PW. Potential impact of magnetic resonance cholangiopan- creatography on endoscopic retrograde cholangiopancreatogra- phy workload and complication rate in patients referred because
  • of abdominal pain. Endoscopy 2001;33:668–75.
  • Lomas DJ, Gimson A. Magnetic resonance cholangiopancreatog- raphy [review]. Hosp Med 2000;61:395–9.
There are 14 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Yasemin Gündüz This is me

Mustafa Kara This is me

Publication Date December 1, 2012
Submission Date September 7, 2015
Published in Issue Year 2012

Cite

AMA Gündüz Y, Kara M. Magnetic resonance cholangio-pancreatography. Sakarya Tıp Dergisi. December 2012;2(4):213-215. doi:10.5505/sakaryamj.2012.65487

30703

SMJ'de yayınlanan makaleler, Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı kapsamında lisanslanır